Javascript must be enabled to continue!
Hypokalemia Improving the Investigation, Management and Therapeutics Monitoring of Hypokalemic Medical Inpatients at Tertiary Care Hospital A Clinical Audit
View through CrossRef
Background: One of the most frequent diseases in hospitalized individuals is Hypokalemia. it is more prevalent in individuals with underlying chronic conditions such as diabetes mellitus, heart failure, or chronic kidney disease (CKD).
Objective: The objective of this audit was for improving the investigation, management and therapeutics monitoring of hypokalemic medical inpatients at tertiary care hospital.
Methodology: The current clinical audit conducted at the department of cardiology, Hayatabad Medical complex Peshawar from January 2018 to December 2021. The audit covered all medical inpatients with hypokalemia during a one-week period. Prior to data collection, a daily list of medical inpatients with confirmed blood potassium levels of less than or equal to 3.4 mmol/L was obtained from the laboratory database in order to identify these individuals. After then, the patient's records were found and examined to determine whether the patient had severe, moderate or mild, hypokalemia.
Results: In the current clinical audit a total of 34 individuals were included in the pre-intervention group. The study found 26(76.4%) individuals with mild hypokalemia (3.1-3.4 mmol/L) & with significant hypokalemia (2.5-3.0 mmol/L) and only three individuals (8.8%) intended an ECG to check for cardiac arrhythmia. 14 (41.1%) participants had repeat U&E analysis after starting therapy. Only 7.5% (20%) of participants had their serum magnesium levels tested. Just eight (23.5%) individuals received proper treatment following conventional standards. Four weeks after the intervention, results were first gathered, and they revealed a significant improvement. Over all 32 individuals were included in the post-intervention group in which 21 were females and 11 were males. 15 participants (46.7%) had moderate hypokalemia (2.5–3.0 mmol/L), and 17 of them (53.2%) had mild hypokalemia (3.1–3.4 mmol/L). There were not any individuals found to have severe hypokalemia (<2.5)
Conclusion: This audit significantly improved management by using a number of initiatives to raise knowledge and comprehension of the evaluations, care, and monitoring of the hypokalemic individuals.
Keywords: Hypokalemia; Management; Therapeutics monitoring
Lahore Medical and Dental College
Title: Hypokalemia Improving the Investigation, Management and Therapeutics Monitoring of Hypokalemic Medical Inpatients at Tertiary Care Hospital A Clinical Audit
Description:
Background: One of the most frequent diseases in hospitalized individuals is Hypokalemia.
it is more prevalent in individuals with underlying chronic conditions such as diabetes mellitus, heart failure, or chronic kidney disease (CKD).
Objective: The objective of this audit was for improving the investigation, management and therapeutics monitoring of hypokalemic medical inpatients at tertiary care hospital.
Methodology: The current clinical audit conducted at the department of cardiology, Hayatabad Medical complex Peshawar from January 2018 to December 2021.
The audit covered all medical inpatients with hypokalemia during a one-week period.
Prior to data collection, a daily list of medical inpatients with confirmed blood potassium levels of less than or equal to 3.
4 mmol/L was obtained from the laboratory database in order to identify these individuals.
After then, the patient's records were found and examined to determine whether the patient had severe, moderate or mild, hypokalemia.
Results: In the current clinical audit a total of 34 individuals were included in the pre-intervention group.
The study found 26(76.
4%) individuals with mild hypokalemia (3.
1-3.
4 mmol/L) & with significant hypokalemia (2.
5-3.
0 mmol/L) and only three individuals (8.
8%) intended an ECG to check for cardiac arrhythmia.
14 (41.
1%) participants had repeat U&E analysis after starting therapy.
Only 7.
5% (20%) of participants had their serum magnesium levels tested.
Just eight (23.
5%) individuals received proper treatment following conventional standards.
Four weeks after the intervention, results were first gathered, and they revealed a significant improvement.
Over all 32 individuals were included in the post-intervention group in which 21 were females and 11 were males.
15 participants (46.
7%) had moderate hypokalemia (2.
5–3.
0 mmol/L), and 17 of them (53.
2%) had mild hypokalemia (3.
1–3.
4 mmol/L).
There were not any individuals found to have severe hypokalemia (<2.
5)
Conclusion: This audit significantly improved management by using a number of initiatives to raise knowledge and comprehension of the evaluations, care, and monitoring of the hypokalemic individuals.
Keywords: Hypokalemia; Management; Therapeutics monitoring.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Hubungan Kualitas Audit, Komite Audit, dan Dewan Pengawas Syariah terhadap Kinerja Bank Umum Syariah di Indonesia
Hubungan Kualitas Audit, Komite Audit, dan Dewan Pengawas Syariah terhadap Kinerja Bank Umum Syariah di Indonesia
ABSTRAK
Penelitian ini ditujukan untuk mengetahui hubungan kualitas audit, komite audit, dan Dewan Pengawas Syariah (DPS) terhadap kinerja Bank Umum Syariah di Indonesia pada tahun...
Paper K-9 Pelaporan Hasil Audit dan Tindak Lanjut Audit Internal
Paper K-9 Pelaporan Hasil Audit dan Tindak Lanjut Audit Internal
Pelaporan hasil audit merupakan komponen utama dalam komunikasi dari audit internal tentang hasil audit. Untuk mengkomunikasikan hasil audit diperlukan susunan laporan, dimana hasi...
Pengaruh Audit Tenure dan Audit Delay terhadap Kualitas Audit
Pengaruh Audit Tenure dan Audit Delay terhadap Kualitas Audit
Abstract. The mining industry contributes significantly to the Indonesian economy, but its complexity requires audit quality to ensure transparency of financial statements. Audit t...
The incidence and risk factors of hypokalemia in hospitalized patients with heart failure
The incidence and risk factors of hypokalemia in hospitalized patients with heart failure
Abstract
Background Potassium plays an important role in the occurrence and progression of heart failure patients,Hypokalemia is one of the most common electrolyte disorder...

